Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Diabetes News

News
Payer Reimbursement Differences in Diabetes Treatments: Public vs Private
04/15/2020
“This study highlights how differences in payer reimbursement rates for medications can lead to contrasting results,” said researchers of a recent study.
“This study highlights how differences in payer reimbursement rates for medications can lead to contrasting results,” said researchers of a recent study.
“This study highlights how...
04/15/2020
First Report Managed Care

Advertisement

News
Diabetes, Chronic Conditions Linked With Higher Health Spending
04/01/2020
“Efforts to alleviate food insecurity should consider the dual burden of chronic conditions,” researchers of a recent study said.
“Efforts to alleviate food insecurity should consider the dual burden of chronic conditions,” researchers of a recent study said.
“Efforts to alleviate food...
04/01/2020
First Report Managed Care
News
Diabetes Medication Adherence Improvements Linked to Mobile Patient Portal Access
02/24/2020
According to the authors of a recent study, “providing patients with computer patient portal access and combining it with mobile patient portal access are associated with significantly improved diabetes medication adherence and glycemic...
According to the authors of a recent study, “providing patients with computer patient portal access and combining it with mobile patient portal access are associated with significantly improved diabetes medication adherence and glycemic...
According to the authors of a...
02/24/2020
Pharmacy Learning Network
News
Why Diabetes Lifestyle Interventions Changed to a Medicare-Covered Service
02/11/2020
Investigators of a recent study found that collaboration, national standards, and public input were key in converting the evidence-based lifestyle intervention from the 2002 Diabetes Prevention Program trial into a service reimbursed by...
Investigators of a recent study found that collaboration, national standards, and public input were key in converting the evidence-based lifestyle intervention from the 2002 Diabetes Prevention Program trial into a service reimbursed by...
Investigators of a recent study...
02/11/2020
First Report Managed Care

Advertisement

News
Economic Burden Associated With CVD in Patients With T1D
02/04/2020
"Cardiovascular comorbidities are common among US adults with T1D," researchers wrote. "Considering their significant economic burden, optimal management is of the utmost importance to improve patient outcomes and reduce healthcare costs."
"Cardiovascular comorbidities are common among US adults with T1D," researchers wrote. "Considering their significant economic burden, optimal management is of the utmost importance to improve patient outcomes and reduce healthcare costs."
"Cardiovascular comorbidities...
02/04/2020
First Report Managed Care
News
Barbershop Intervention May Reach Men With Undiagnosed Diabetes, Prediabetes
01/28/2020
These findings are encouraging, especially because the prevalence of diabetic complications is disproportionately high in black men compared with men of other racial and ethnic groups.
These findings are encouraging, especially because the prevalence of diabetic complications is disproportionately high in black men compared with men of other racial and ethnic groups.
These findings are encouraging,...
01/28/2020
Pharmacy Learning Network
News
Pharmacist Intervention Improves Blood Pressure, Diabetes Outcomes in Homeless
01/17/2020
“Homeless patients with hypertension and/or type 2 diabetes who had at least one visit with a pharmacist showed some improved health outcomes,” researchers wrote.
“Homeless patients with hypertension and/or type 2 diabetes who had at least one visit with a pharmacist showed some improved health outcomes,” researchers wrote.
“Homeless patients with...
01/17/2020
Pharmacy Learning Network

Advertisement

News
Adverse Drug Events Underreported Among Patients Taking Apixaban, Empagliflozin
01/07/2020
“We found substantial underreporting of apixaban and empagliflozin [adverse drug events] that became worse at each higher level of spontaneous reporting,” researchers explained.
“We found substantial underreporting of apixaban and empagliflozin [adverse drug events] that became worse at each higher level of spontaneous reporting,” researchers explained.
“We found substantial...
01/07/2020
Pharmacy Learning Network
News
Cost Savings Associated With Digital Therapeutics for Patients With Diabetes, Hypertension
12/13/2019
Researchers recently examined the economic impact of a digital behavioral intervention in type 2 diabetes mellitus and hypertension and found that digital therapeutics may provide substantial cost savings.
Researchers recently examined the economic impact of a digital behavioral intervention in type 2 diabetes mellitus and hypertension and found that digital therapeutics may provide substantial cost savings.
Researchers recently examined...
12/13/2019
First Report Managed Care
News
ADA Guideline Compliance Results in Lower Costs, Fewer Hospital Visits
11/13/2019
When American Diabetes Association (ADA) guideline recommendations are followed, researchers found that there is a significant reduction in total annual health care, inpatient-hospitalization, and emergency room expenditures among patients...
When American Diabetes Association (ADA) guideline recommendations are followed, researchers found that there is a significant reduction in total annual health care, inpatient-hospitalization, and emergency room expenditures among patients...
When American Diabetes...
11/13/2019
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

What's Trending?

Try This
The Pittsburgh Sleep Quality Index
01/21/2013
While normal aging changes interfere with the quality of sleep, other disease conditions and medications used by older adults compromise sleep patterns.
While normal aging changes interfere with the quality of sleep, other disease conditions and medications used by older adults compromise sleep patterns.
While normal aging changes...
01/21/2013
Annals of Long-Term Care
Behind the Bill
September 18, 2024
09/18/2024
The aftermath of legal challenges and state legislation continues to reshape the landscape of copay accumulator programs, forcing payers and manufacturers to adapt their strategies.
The aftermath of legal challenges and state legislation continues to reshape the landscape of copay accumulator programs, forcing payers and manufacturers to adapt their strategies.
The aftermath of legal...
09/18/2024
First Report Managed Care
Review
End-of-Life Nutrition: Is Tube Feeding the Solution?
10/17/2013

Liz Friedrich, MPH, RD, CSG, LDN

Series Editor: Liz Friedrich, MPH, RD, CSG, LDN

Liz Friedrich, MPH, RD, CSG, LDN Ser...
One decision regarding nutrition care is whether to use percutaneous endoscopic gastrostomy (PEG) tube feeding in elderly or terminally ill residents.
One decision regarding nutrition care is whether to use percutaneous endoscopic gastrostomy (PEG) tube feeding in elderly or terminally ill residents.
One decision regarding nutrition...
10/17/2013
Annals of Long-Term Care
Review
Management of Vulvovaginal Disorders in Older Women
04/13/2020
Rohani Manda, MD
Nader Tavakoli, MD, CMD, FAAFP
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD
Nkenna Odom, MD
Stacy Ross, MD
Tiffany Mapp, MD
The objective of this paper is to emphasize the common vulvovaginal problems, other than infections, in older women and their management.
The objective of this paper is to emphasize the common vulvovaginal problems, other than infections, in older women and their management.
The objective of this paper is...
04/13/2020
Annals of Long-Term Care
More Generics, Biosimilars, and Orphan Drugs on the Horizon
11/14/2014

Jill Sederstrom

Jill Sederstrom
As patented products expire, >$13 billion in brand-name specialty medications are expected to face generic competition in the next 5 years, and it is projected that there is a $31.8 billion opportunity in the market for biosimilars through...
As patented products expire, >$13 billion in brand-name specialty medications are expected to face generic competition in the next 5 years, and it is projected that there is a $31.8 billion opportunity in the market for biosimilars through...
As patented products expire,...
11/14/2014
First Report Managed Care

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use